Skip to main content

Table 2 Descriptive characteristics of subjects with tPSA 4–10 ng/mL

From: Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study

  Total No cancer Cancer P value
  N, 77  N, 48 (62.3%) N, 29 (37.7%)
Age, yr 68.0 (12.0) 66.5 (11.0) 71.0 (12.0) 0.010
tPSA, ng/mL 6.41 (2.5) 6.42 (2.3) 6.13 (2.8) 0.877
fPSA 0.92 (0.5) 0.97 (0.6) 0.92 (2.4) 0.185
%fPSA 15.49 (8.6) 16.83 (7.5) 13.04 (7.1) 0.284
p2PSA, pg/mL 16.86 (17.5) 15.34 (16.1) 17.09 (23.7) 0.189
%p2PSA 1.61 ( 1.6) 1.50 (1.0) 2.35 (2.6) 0.015
PHI 41.35 (37.9) 39.65 (28.9) 53.72 (56.8) 0.018
Positive core number 4.0 (7.0)
Number (percentage)
GS 6 9 (31%)
GS 7    10 (34.5%)
GS ≥ 8    10 (34.5%)
  1. Data are shown as median (interquartile range), or number (%)
  2. PSA, prostate-specific antigen; tPSA, total PSA; fPSA, free PSA; p2PSA, [2]proPSA; PHI, prostate health index; GS, Gleason score
  3. P value to be statiscally significant with bolditalics